Freeport-McMoRan Inc vs Revvity Inc — how do they compare? Freeport-McMoRan Inc trades at $70.13 (market cap $96.42B), while Revvity Inc trades at $116.5 (market cap $12.91B). The key difference: Freeport-McMoRan Inc is far larger — about 7.5× Revvity Inc's market cap, and Freeport-McMoRan Inc pays the higher dividend (0.87%). Which is the better fit depends on your goals.
| FCX | RVTY | |
|---|---|---|
Market Cap | $96.42B | $12.91B |
Sector | Basic Materials | Technology |
52-Week High | $71.73 | $117.75 |
52-Week Low | $35.34 | $82.26 |
Enterprise Value | $102.70B | $15.23B |
Dividend Yield | 0.87% | 0.24% |
Signals from Pluang's Aura AI — not financial advice
FCX trades at $70.53, up 1.31% today, with a bullish technical signal and strong analyst support. Recent earnings beats and robust cash flow from operations highlight operational strength. The stock is near its consensus price target of $73.85, with copper market tailwinds and growth initiatives like the Grasberg ramp-up providing positive momentum.
The outlook is positive given earnings momentum and favorable copper prices, but risks include commodity price volatility and execution challenges. With a P/E of 33.76, valuation is elevated, yet growth prospects justify investor optimism. Key risks are macroeconomic sensitivity and capital expenditure demands.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →